Skip to main content

Table 3 Concurrent validity by correlation of MDASI-MPM subscale scores with LCSS-Meso score at various timepoints

From: Evaluation of the psychometric properties and minimally important difference of the MD Anderson Symptom Inventory for malignant pleural mesothelioma (MDASI-MPM)

 

Sample size

MDASI-MPM symptomsa

MDASI-MPM interferencea

Baseline

238

0.73

0.74

Cycle 2 Day 1

197

0.80

0.75

Cycle 3 Day 1

161

0.78

0.76

Cycle 4 Day 1

131

0.80

0.78

Cycle 5 Day 1

110

0.80

0.77

Safety follow-up

95

0.78

0.79

  1. aMDASI-MPM symptoms = the average of the 13 core and 6 MPM-specific items. MDASI-MPM interference = the average of the 6 interference items
  2. Abbreviations: LCSS-Meso Lung Cancer Symptom Scale-Mesothelioma, MDASI-MPM MD Anderson Symptom Inventory for malignant pleural mesothelioma